Navigation Links
Independent Publication Confirms Growing Therapeutic Challenge of,T315I Mutation in Patients with CML, Notes ChemGenex

MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)--May 21, 2007 - ChemGenex Pharmaceuticals (ASX: CXS, NASDAQ: CXSP) notes the publication of new clinical data relevant to the development strategy for Ceflatonin(R) (homoharringtonine). The paper "Targeted therapy and the T315I mutation in Philadelphia-positive leukemias" by researchers Simona Soverini and colleagues at the University of Bologna, Italy (Haematologica Volume 92, pages 401-404) offers insight into the growing therapeutic challenge presented by the T315I Bcr-Abl point mutation in patients with chronic myeloid leukemia (CML). The T315I Bcr-Abl mutation is associated with the development of resistance to tyrosine kinase inhibitor drugs such as imatinib (Gleevec(R)).

The paper describes the clinical progress of Gleevec-resistant CML patients who were treated with dasatinib (Sprycel(R)).

Key points of the publication are as follows:

-- The study followed 45 Philadelphia-positive CML and acute lymphoblastic leukemia (ALL) patients who had failed Gleevec, and who were migrated to dasatinib therapy.

-- Eight of the 45 patients (17.7%) had primary resistance to dasatinib, and showed no response. Seven of these 8 patients harboured the T315I point mutation.

-- A further 13 patients (28.8%) acquired resistance to dasatinib after a median of 7 months, and seven (15.6%) of these patients were T315I positive.

-- In summary the T315I mutation was associated with resistance to dasatinib in 31% of patients, and the total number of patients who were resistant to therapy was 46.7%.

-- This incidence of T315I-associated resistance is higher than has previously been reported and reflects, in the words of Soverini et al., that the T315I mutation "is likely to become the prevalent mutation in those who fail to benefit from second-line treatment with dasatinib".

Data from this publication support ChemGenex's t
'"/>




Page: 1 2 3

Related medicine technology :

1. Molecular Target of Bradmers Neuradiab Further Validated by Independent Findings
2. Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex
3. Study Continues to Show Patients With Myelodysplastic Syndromes Treated With Revlimid are Living Longer and Remaining Transfusion Independent
4. Independent publication supports the profile of CeNeS phase II compound, CNS 5161
5. Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Growth of Both Hormone-Dependent and Hormone-Independent Prostate Cancer by Up to 94 Percent in Preclinical Studies
6. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
7. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
8. Publication Confirms that EpCAM, the Target for Two of Micromets Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers
9. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
10. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
11. Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in Journal of American College of Cardiology
Post Your Comments:
(Date:5/21/2013)... , May 21, 2013  Lehigh Valley Health Network ... TM devices, adding to its existing arsenal of ... taking up residence within the network, LVHN is now ... to proactively combat superbugs and provide the best possible ... Room Ultraviolet Disinfector, TRU-D – the signature product of ...
(Date:5/21/2013)... SUNNYVALE, Calif. , May 21, 2013 /PRNewswire/ ... ), announced today the publication of study results ... the CyberKnife® Robotic Radiosurgery System, the most widely ... (SBRT). The study followed 304 patients for a ... years post-treatment and found that 97 percent of ...
(Date:5/21/2013)... 21, 2013  Janssen R&D Ireland (Janssen) today ... global Phase 3 PROMISE study demonstrating that use ... to sustained virologic response 12 weeks after the ... treatment-experienced genotype 1 chronic hepatitis C adult patients ... liver fibrosis, when administered once daily with pegylated ...
Breaking Medicine Technology:Lehigh Valley Expands Fleet of Superbug-Slaying Robots 2Lehigh Valley Expands Fleet of Superbug-Slaying Robots 3New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7
(Date:5/21/2013)... 21, 2013 Five million Americans will ... who do, Tiffany Liashek, owner of Studio South ... a long look at credentials and experience. The variation ... she says. “A trainer can pay $69.50 and get ... , Good trainers invest in themselves, A serious, professional ...
(Date:5/21/2013)... 2013 Third Generation Master Barber Greg ... first two barbering DVDs. These DVDs include content from ... school , cosmetology school or are current professionals, will ... an experienced teacher and mentor. , Today’s modern men’s ... 1920’s – 1960’s time period. In order to efficiently ...
(Date:5/21/2013)... May 21, 2013 Dallas-based TopMD™ Skin ... journal article testing the efficacy of their flagship product, ... The clinical study results appear in the May/June 2013 ... article, “A Novel Sodium Hypochlorite Cleanser Shows Clinical Response ... reports impressive findings seen after consistent use of the ...
(Date:5/21/2013)... Everspark Interactive, one of the city's leading online marketing ... past year – and announced another milestone this week ... for Kids II, a designer of innovative baby toys ... effort, specializing in search engine optimization (SEO) or the ... The company now offers a host of boutique online ...
(Date:5/21/2013)... Beginning May 21st, 2013, DTP Sales ... 8000, the newest in digital recording technology, to the ... product for anyone looking to get the most from ... 8000 is expected to have revolutionary options and ... voice recorder features and highlights: , ...
Breaking Medicine News(10 mins):Health News:Sarasota Fitness Tips: Choosing a Safe Trainer and Gym 2Health News:Sarasota Fitness Tips: Choosing a Safe Trainer and Gym 3Health News:First Series of Barbering DVDs Launched by Third Generation Master Barber Greg Zorian; DVDs Teach the Art of Men's Haircutting, Clipper Cutting, Fades and More 2Health News:First Series of Barbering DVDs Launched by Third Generation Master Barber Greg Zorian; DVDs Teach the Art of Men's Haircutting, Clipper Cutting, Fades and More 3Health News:First Series of Barbering DVDs Launched by Third Generation Master Barber Greg Zorian; DVDs Teach the Art of Men's Haircutting, Clipper Cutting, Fades and More 4Health News:First Series of Barbering DVDs Launched by Third Generation Master Barber Greg Zorian; DVDs Teach the Art of Men's Haircutting, Clipper Cutting, Fades and More 5Health News:First Series of Barbering DVDs Launched by Third Generation Master Barber Greg Zorian; DVDs Teach the Art of Men's Haircutting, Clipper Cutting, Fades and More 6Health News:Peer-Reviewed Article Shows CLn® BodyWash an Effective Solution for Children with Eczema 2Health News:Peer-Reviewed Article Shows CLn® BodyWash an Effective Solution for Children with Eczema 3Health News:Everspark Named Interactive Marketing Company for Kids II 2Health News:DTP Sales & Service Announces Upcoming Availability Of Philips Pocket Memo 8000 Series 2
... They could fight cancer, heart disease, researchers say , , MONDAY, ... your life, a new European study suggests. , "The ... mortality from any cause of death," said lead researcher Dr. ... in Lyon, France. , The new finding, published in the ...
... the Association for Assessment and Accreditation of Laboratory ... standard for animal care facilities, AAALAC accreditation is ... the humane care and use of animals in ... involves a comprehensive review by AAALAC evaluators, who ...
... out-of-pocket health care costs, CAMP HILL, Pa., Sept. ... to help consumers compare health plan options and,choose one ... is available,to consumers on Highmark member Web sites. ... said Kim,Bellard, Vice President of eMarketing and Customer Relationship ...
... 10 portionpals(R), the fastest growing,weight loss tool ... million,sales mark with no national retail distribution in ... are coming strictly from word-of-mouth," says Matt,Zucker, VP ... Moose,of Manistique, Michigan became our 250,000 customer! "Our ...
... researchers have found that first-degree relatives (i.e., parents, siblings, ... more likely to have the biomarker of the disease ... could screen and assess first-degree relatives of PBC patients ... and treat more patients before the disease causes irreversible ...
... well after therapy ends , , MONDAY, Sept. 10 (HealthDay ... breast cancer survivors still report more days of fatigue ... fatigue is likely a long-term effect of chemotherapy, according ... complaint for most people and is also reported by ...
Cached Medicine News:Health News:Vitamin D Supplements May Lengthen Life 2Health News:UCSF animal care facility receives top accreditation 2Health News:Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers 2Health News:New research may lead to earlier diagnosis and treatment of primary biliary cirrhosis in families 2Health News:Long-Term Fatigue Plagues Cancer Survivors 2
... Sun Design chairs offer support and ... of the chair are designed to take ... maximum comfort. The seat height and angle ... a single lever. The seat can be ...
Heine Beta 200 Streak Retinoscope 2.5v...
Video Equipment...
Portable mini halogen light....
Medicine Products: